Group B Streptococcus Screening and Prevention
Introduction to GBS Screening
- The American College of Obstetricians and Gynecologists (ACOG) and the Centers for Disease Control and Prevention (CDC) recommend screening all pregnant women for GBS colonization at 36 0/7 to 37 6/7 weeks of gestation through vaginal-rectal swab culture, as this timing provides the best sensitivity and specificity for detecting women who will remain colonized at delivery 1, 2, 3
- Group B Streptococcus (GBS) is a major cause of neonatal morbidity and mortality, and guidelines recommend screening and prevention strategies to reduce the risk of early-onset disease in infants 1, 2
Proper Collection Technique
- The CDC guidelines state that specimens should be collected from both the lower vagina (vaginal introitus) followed by the rectum (through anal sphincter), and a speculum should not be used for culture collection, with the specimens placed into a nonnutritive transport medium 1
- Cultures should be collected in the outpatient setting by the healthcare provider or, with appropriate instruction, by the patient herself, and placed into a nonnutritive transport medium, as recommended by the CDC 1, 2
Screening in Preterm Labor
- For women presenting with signs and symptoms of preterm labor (<37 weeks), the CDC recommends obtaining a vaginal-rectal swab for GBS culture at hospital admission unless a culture was performed within the preceding 5 weeks, and starting GBS prophylaxis while awaiting culture results 1
Intrapartum Antibiotic Prophylaxis
- The CDC guidelines recommend that women who should receive intrapartum antibiotic prophylaxis include those with positive GBS screening at 36 0/7 to 37 6/7 weeks, those with GBS bacteriuria during the current pregnancy, those with a previous infant with invasive GBS disease, and those with unknown GBS status at labor onset who have risk factors 1
- Women with GBS bacteriuria during current pregnancy should receive intrapartum antibiotic prophylaxis without additional screening, regardless of the colony count, as recommended by the CDC and ACOG 1, 4, 3
- Women who previously delivered an infant with invasive GBS disease should receive intrapartum antibiotic prophylaxis without screening, as recommended by the CDC and ACOG 1, 3
- Intrapartum antibiotic prophylaxis should be given to all pregnant women who test positive for GBS colonization, except for those undergoing Cesarean delivery before onset of labor with intact amniotic membranes, as recommended by the CDC and ACOG 1
- Intrapartum antibiotic prophylaxis should be given when screening results are unavailable if any of the following risk factors are present: delivery at <37 weeks' gestation, amniotic membrane rupture ≥18 hours, or intrapartum temperature ≥100.4°F (≥38.0°C), as recommended by the CDC and ACOG 1
- When indicated, intrapartum antibiotic prophylaxis should consist of intravenous penicillin G (5 million units initially, then 2.5 million units every 4 hours until delivery), as recommended by the CDC and ACOG 1
- Ampicillin is an acceptable alternative to penicillin G, but penicillin G is preferred due to its narrower spectrum, according to the CDC and ACOG 4
- For women with penicillin allergy, susceptibility testing for clindamycin and erythromycin should be ordered on positive GBS cultures, as recommended by the CDC 1
Non-Recommended Practices
- Antimicrobial agents should not be used before the intrapartum period to eradicate GBS colonization, as this is ineffective and may cause adverse consequences, as stated by the CDC and ACOG 1, 4
- Treating GBS-positive women with oral antibiotics during pregnancy is not effective in eliminating carriage or preventing neonatal disease, according to the CDC and ACOG 1, 4
- Relying on previous pregnancy results is not recommended, as GBS status in a previous pregnancy does not predict current status unless there was a previous GBS-affected infant, as stated by the CDC and ACOG 1
Risk Factors and Indications
- Maternal GBS colonization is a major risk factor for early-onset disease in infants, according to the CDC 2
- Women with prenatal GBS colonization are >25 times more likely to deliver infants with early-onset GBS disease compared to women with negative cultures, as stated by the CDC 2
- A negative vaginal and rectal GBS screening culture in late gestation during the current pregnancy is a non-indication for prophylaxis, regardless of intrapartum risk factors, according to the CDC 1
- Prior GBS colonization in a previous pregnancy without a previous GBS-affected infant is not an indication for prophylaxis in the current pregnancy, as stated by the CDC and ACOG 1
- Cesarean delivery performed before onset of labor on a woman with intact amniotic membranes is a non-indication for prophylaxis, regardless of GBS colonization status or gestational age, as recommended by the CDC and ACOG 1